Lafayette, IN, United States of America

David T Jonaitis


 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **David T. Jonaitis: Innovator in Pharmaceutical Chemistry**

Introduction

David T. Jonaitis is a notable inventor based in Lafayette, Indiana, recognized for his contributions to pharmaceutical innovations. With a remarkable portfolio that includes 11 patents, he has made significant strides in the field of medicinal chemistry, focusing on the development of compounds aimed at treating various health conditions.

Latest Patents

Among Jonaitis' latest patents are innovative forms of CDDO methyl ester, a triterpenoid compound. This compound exists in both a non-crystalline, glassy solid form and a non-hydrous crystalline form, which can be synthesized from a saturated methanol solution. Notably, the glassy form demonstrates enhanced bioavailability compared to its non-hydrous crystalline counterpart, making it a superior candidate for solid dosage forms in treating inflammation-related diseases.

Another key patent involves solid-state forms of racemic ilaprazole, a compound designed to inhibit gastric acid secretion. Jonaitis' invention not only describes crystalline forms of ilaprazole but also outlines a pharmaceutical composition incorporating these forms in an effective manner to treat various acid-related gastrointestinal disorders, thereby showcasing his expertise in drug formulation.

Career Highlights

David T. Jonaitis has had an impactful career working with prestigious organizations including Il Yang Pharmaceutical Company and Reata Pharmaceuticals, Inc. His work in these companies underscores his expertise in developing innovative pharmaceutical solutions and his ability to contribute to leading-edge research in the chemistry of pharmaceuticals.

Collaborations

Throughout his career, Jonaitis has collaborated with esteemed colleagues such as Stephan D. Parent and John M. Brackett. These partnerships have enabled him to expand his research capabilities and drive innovation in the pharmaceutical sector.

Conclusion

In summary, David T. Jonaitis has proven himself as a prolific inventor in the realm of pharmaceutical chemistry. With a focus on enhancing drug formulations and developing novel therapeutic compounds, his contributions are invaluable to the field. His ongoing work continues to inspire advances in medication that aim to improve the quality of patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…